Equities

Vimta Labs Ltd

VIMTALABS:NSI

Vimta Labs Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)563.65
  • Today's Change-6.35 / -1.11%
  • Shares traded122.54k
  • 1 Year change+4.77%
  • Beta1.1138
Data delayed at least 15 minutes, as of Sep 20 2024 11:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Vimta Labs Ltd's net income fell -14.87% from 481.72m to 410.09m despite flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 46.87% to 48.53%.
Gross margin76.48%
Net profit margin12.98%
Operating margin16.67%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in INRView more

In 2024, cash reserves at Vimta Labs Ltd fell by 170.59m. However, the company earned 608.92m from its operations for a Cash Flow Margin of 19.13%. In addition the company used 760.48m on investing activities and also paid 19.03m in financing cash flows.
Cash flow per share33.44
Price/Cash flow per share16.83
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in INRView more

Vimta Labs Ltd uses little or no debt in its capital structure.
Current ratio--
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in INR

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -14.55%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)0.60%
Div growth rate (5 year)0.00%
Payout ratio (TTM)10.79%
EPS growth(5 years)9.77
EPS (TTM) vs
TTM 1 year ago
-14.41
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.